The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Trevena, Inc(NASDAQ:TRVN) 
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the m...
Website: http://www.trevena.com
Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
Trevena Days Payable Outstanding ttm (DPO)
Trevena Days Receivable Outstanding ttm (DSO)
Trevena Days Inventory Outstanding ttm (DIO)
Trevena Op Cashflow Per Share ttm
Trevena Free Cashflow Per Share ttm
Trevena Cash Per Share ttm
Trevena P/S ratio ttm
Trevena (GAAP) P/E ratio ttm
Trevena P/B ratio ttm
No extra charts and metrics for this ticker.